Literature DB >> 11008914

Correlates of the spread of human papillomavirus infection.

I Silins1, I Kallings, J Dillner.   

Abstract

Knowledge of the correlates of human papillomavirus (HPV) seropositivity is of interest for planning of preventive measures and for evaluation of possible confounding in epidemiological studies. The epidemiological determinants for seropositivity for oncogenic and benign HPV types were assessed using a serosurvey of 275 healthy Swedish women, stratified by age and lifetime number of sexual partners. Seroprevalences were compared with 17 behavioral variables obtained by interview and 3 laboratory-diagnosed microbiological exposures. In univariate analysis, history of gonorrhea and condylomatosis, human herpesvirus type 8 and herpes simplex virus 2 seropositivities, lifetime number of sexual partners, and current partner's lifetime number of sexual partners were associated with oncogenic HPV seropositivity. Noteworthy lack of correlations included smoking habits and oral contraceptive use. In multivariate analysis, only the number of lifetime sexual partners [odds ratio (OR), 8.7; 95% confidence interval (CI), 3.3-22.6] and seropositivity for benign HPV types remained significant (OR, 2.9; 95% CI, 1.6-5.3). Seropositivity for benign HPV was primarily associated with condyloma history (OR, 3.6; 95% CI, 1.2-10.8) and seropositivity for oncogenic HPV (OR, 2.9; 95% CI, 1.6-5.2). An association with sexual history lost significance in the multivariate model. In conclusion, lifetime number of sexual partners is the major determinant of acquisition of oncogenic HPV. By contrast, benign HPV infection associates more strongly with condyloma history than with sexual history per se.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11008914

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  13 in total

Review 1.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

2.  Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites.

Authors:  Kristina R Dahlstrom; Guojun Li; Guillermo Tortolero-Luna; Qingyi Wei; Erich M Sturgis
Journal:  Head Neck       Date:  2010-08-24       Impact factor: 3.147

Review 3.  Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination.

Authors:  J Dillner; M Arbyn; L Dillner
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

Review 4.  Monitoring of human papillomavirus vaccination.

Authors:  J Dillner; M Arbyn; E Unger; L Dillner
Journal:  Clin Exp Immunol       Date:  2010-11-09       Impact factor: 4.330

5.  Association of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women.

Authors:  Yan Tong; Aaron Ermel; Wanzhu Tu; Marcia Shew; Darron R Brown
Journal:  J Med Virol       Date:  2013-07-16       Impact factor: 2.327

6.  DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women.

Authors:  Aaron C Ermel; Marcia L Shew; Bree A Weaver; Brahim Qadadri; Cheryl Denski; Wanzhu Tu; Yan Tong; J D Fortenberry; Darron R Brown
Journal:  Sex Transm Infect       Date:  2013-09-12       Impact factor: 3.519

7.  Assessing perceived risk and STI prevention behavior: a national population-based study with special reference to HPV.

Authors:  Amy Leval; Karin Sundström; Alexander Ploner; Lisen Arnheim Dahlström; Catarina Widmark; Pär Sparén
Journal:  PLoS One       Date:  2011-06-02       Impact factor: 3.240

Review 8.  Aspects of prophylactic vaccination against cervical cancer and other human papillomavirus-related cancers in developing countries.

Authors:  Kari Natunen; Johannes Lehtinen; Proscovia Namujju; John Sellors; Matti Lehtinen
Journal:  Infect Dis Obstet Gynecol       Date:  2011-07-19

9.  Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists.

Authors:  Janice C Raley; Kristen A Followwill; Gregorgy D Zimet; Kevin A Ault
Journal:  Infect Dis Obstet Gynecol       Date:  2004 Sep-Dec

10.  Serological prevalence and persistence of high-risk human papillomavirus infection among women in Santiago, Chile.

Authors:  Felipe A Castro; Angelica Dominguez; Klaus Puschel; Vanessa Van De Wyngard; Peter J F Snijders; Silvia Franceschi; Michael Pawlita; Catterina Ferreccio
Journal:  BMC Infect Dis       Date:  2014-07-03       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.